4.1 Article

Biocompatible nanoparticles and gadolinium complexes for MRI applications

Journal

COMPTES RENDUS CHIMIE
Volume 16, Issue 6, Pages 531-539

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.crci.2012.12.010

Keywords

Imaging agents; Lanthanides; Macrocyclic ligands; Nanotechnology; Nanostructures; Copolymers; Gels

Funding

  1. Region Champagne-Ardenne
  2. EU-program FEDER
  3. ARC [00/05-258, 05/10-335, AUWB-2010-10/15-UMONS-5]
  4. FNRS, ENCITE program
  5. COST actions [TD1004, CD1006]
  6. European Network of Excellence EMIL (European Molecular Imaging Laboratories) program [LSCH-2004-503569]
  7. Center for Microscopy and Molecular Imaging (CMMI)
  8. European Regional Development Fund
  9. Walloon Region

Ask authors/readers for more resources

Performances of double-emulsion techniques (W/O/W and W/O/O) and ionotropic gelation process were compared to achieve encapsulation of gadolinium MRI contrast agents (GdCAs) into biocompatible polymeric nanopartides (NPs) with high Gd-loadings. The better approach proved to be ionotropic gelation with H[Gd(DOTA)] as GdCA. Relaxometry evaluation of H[Gd(DOTA)]subset of NPs efficiency demonstrated that incorporation of H[Gd(DOTA)] inside an hydrogel matrix highly improved H[Gd(DOTA)] relaxivity. Particle efficacy as MR contrast agents was further demonstrated on a 3 T clinical imager: a significant improvement of T-1- and T-2- MR signals was obtained at doses much lower than the currently used. (C) 2012 Academie des sciences. Published by Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available